Why carry out this study?

Dry eye disease (DED) therapies targeting specific mechanisms involved in meibomian gland dysfunction (MGD), such as microblepharoexfoliation (MBE), intense pulse light (IPL) and meibomian gland expression (MGX), have been shown to be safe and effective on an individual basis. However, the effects of combining these therapies do not appear to be sufficiently studied.

This study evaluates the efficacy and safety of MBE-IPL-MGX combination treatment in patients with DED owing to MGD.

What was learned from the study?

MBE-IPL-MGX combination treatment improves dry eye symptoms and signs as well as meibomian gland function compared to control group.

Our findings suggest that three sessions of this combined treatment are effective and safe for the treatment of MGD, especially in the most severe stages.